Withdrawing FDA Approval of Midodrine After Marketing

被引：2

作者：

Holtzman, Neil A. ^{[1
]}

Starfield, Barbara ^{[1
]}

机构：

[1] Johns Hopkins Med Inst, Baltimore, MD 21205 USA

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2011年 / 305卷 / 08期

关键词：

D O I：

10.1001/jama.2011.161

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：781 / 782

页数：2

共 50 条

[1] Withdrawing FDA Approval of Midodrine After Marketing Reply
Dhruva, Sanket S.
Redberg, Rita F.
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (08): : 782 - 782
[2] Trials to Address Efficacy of Midodrine 18 Years After It Gains FDA Approval
Mitka, Mike
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (11): : 1124 - 1127
[3] FDA grants final marketing approval for Corlopam
不详
[J]. DRUG NEWS & PERSPECTIVES, 1997, 10 (08) : 482 - 482
[4] US FDA scientists point to gaps in approval, marketing
[J]. Reactions Weekly, 2005, 1034 (1) : 4 - 4
[5] Withdrawing Approval of Makena - A Proposal from the FDA Center for Drug Evaluation and Research
Chang, Christina Y.
Nguyen, Christine P.
Wesley, Barbara
Guo, Jia
Johnson, Laura Lee
Joffe, Hylton V.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (24):
[6] GelTex, Genzyme announce FDA marketing approval for RenaGel capsules
不详
[J]. DIALYSIS & TRANSPLANTATION, 1999, 28 (01) : 9 - 9
[7] Withdrawing Approval of Makena-A Proposal From the FDA Center for Drug Evaluation and Research
Norton, Mary E.
[J]. OBSTETRICAL & GYNECOLOGICAL SURVEY, 2021, 76 (05) : 253 - 253
[8] PALINODE BY FDA REGARDING MIDODRINE
Jose Manuel, Lopez Tricas
[J]. ATENCION FARMACEUTICA, 2011, 13 (02): : 67 - 68
[9] First new insulin in 14 years receives FDA marketing approval
不详
[J]. DIALYSIS & TRANSPLANTATION, 1996, 25 (08) : 500 - 500
[10] Accelerated Approval and Possible Withdrawal of Midodrine
Dhruva, Sanket S.
Redberg, Rita F.
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 304 (19): : 2172 - 2173

← 1 2 3 4 5 →